Takeda Pharmaceutical Co Ltd
Change company Symbol lookup
Select an option...
TKPHF Takeda Pharmaceutical Co Ltd
O Realty Income Corp
HSTA Hestia Insight Inc
NRG NRG Energy Inc
MACK Merrimack Pharmaceuticals Inc
BMY Bristol-Myers Squibb Co
NDAQ Nasdaq Inc
UL Unilever PLC
SF Stifel Financial Corp
NRGD MicroSectors? U.S. Big Oil Index -3X Inverse Leveraged ETNs
Go


Based in Japan
Company profile

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Closing Price
$29.72
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
30,175
0

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.